Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Innate Pharma (IPHA) Other Operating Expenses (2024)

Historic Other Operating Expenses for Innate Pharma (IPHA) over the last 1 years, with Q4 2024 value amounting to -$0.0.

  • Innate Pharma's Other Operating Expenses changed N/A to -$0.0 in Q4 2024 from the same period last year, while for Jun 2025 it was $1076.9, marking a year-over-year change of 0.0%. This contributed to the annual value of $0.0 for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Innate Pharma's Other Operating Expenses stood at -$0.0.
  • Over the past 5 years, Innate Pharma's Other Operating Expenses peaked at $1076.9 during Q2 2024, and registered a low of -$0.0 during Q4 2024.